Investigating the Role of Mucin and Mucin Glycosylating Enzymes in Nasopharyngeal Carcinoma and Salivary Gland Cancer and Their Correlation With Clinical Prognosis

• Conditions: Nasopharyngeal Carcinoma; Salivary Gland Cancer

• Registration Number: NCT02401763
• Lead Sponsor: National Taiwan University Hospital

Brief Summary

Nasopharyngeal carcinoma (NPC) is the tenth leading cancers in Taiwan and investigating its biomarker is important for understanding the mechanism of its pathogenesis.

Detailed Description

NPC is the tenth leading cancers in Taiwan and investigating its biomarker is important for understanding the mechanism of its pathogenesis.

Study Timeline

• Status Verified: 2015-03
• Study First Submitted: 2015-03-18
• Study First Submitted QC: 2015-03-27
• Study First Posted: 2015-03-30
• Last Update Submitted: 2015-03-31
• Study Start: 2015-04
• Last Update Posted: 2015-04-03
• Primary Completion: 2016-04

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• NPC and salivary gland tumor diagnosed and treated in HTUH

Exclusion Criteria

• previous treatment or surgery

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The difference of expression level of mucin glycosylating enzymes (by immunohistochemistry) in nasopharyngeal carcinoma and salivary gland tissues	1~5 years after patients received definite therapy